Exposure to statins post localized prostate cancer diagnosis and risk of metastasis among men who did not receive curative prostate cancer treatment-Reference-Cited by-同舟云学术

Exposure to statins post localized prostate cancer diagnosis and risk of metastasis among men who did not receive curative prostate cancer treatment

Published:2022-11-08 Issue:3 Volume:6 Page:
ISSN:2573-8348
Container-title:Cancer Reports
language:en
Short-container-title:Cancer Reports

Author:

Habeshian Talar S.¹^ORCID,Shu Yu‐Hsiang¹,Cannavale Kimberly L.¹^ORCID,Slezak Jeff M.¹^ORCID,Chien Gary W.²,Vandeneeden Stephen K.³,Chao Chun R.¹^ORCID

Affiliation:

1. Department of Research and Evaluation Kaiser Permanente Southern California Pasadena California USA

2. Department of Urology, Los Angeles Medical Center Kaiser Permanente Southern California Los Angeles California USA

3. Division of Research Kaiser Permanente Northern California Oakland California USA

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cnr2.1749

Reference22 articles.

1. American Cancer Society.Cancer Facts & Statistics.2021. Accessed March 2021.

2. U.S. Cancer Statistics Working Group.U.S. Cancer Statistics Data Visualizations Tool based on 2019 submission data (1999–2017): U.S. Department of Health and Human Services Centers for Disease Control and Prevention and National Cancer Institute.2020. Accessed March 2021.

3. Stage-specific incidence rates and trends of prostate cancer by age, race, and ethnicity, United States, 2004–2014

4. Long‐term follow‐up of a racially and ethnically diverse population of men with localized prostate cancer who did not undergo initial active treatment

5. In vitro and in vivo downregulation of the ATP binding cassette transporter B1 by the HMG-CoA reductase inhibitor simvastatin